| Gene symbol | MAGEA4 | Synonyms | CT1.4, MAGE-41, MAGE-X2, MAGE4, MAGE4A, MAGE4B | Type of gene | protein-coding |
| Chromosome | X | Map location | Xq28 | dbXrefs | |
| Description | MAGE family member A4 | ||||
| GTO ID | GTC3689 |
| Trial ID | NCT06170294 |
| Disease | Advanced Solid Tumor |
| Altered gene | MAGE-A4 |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | MAGE-A4 TCR-T cells |
| HLA | HLA-A*02 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | A Single-arm, Open-label, Dose Exploratory Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Autologous Humanized MAGE-A4-directed T Cell Receptor Engineered T Cell (JWTCR001) in Patients With Advanced Solid Tumors |
| Year | 2023 |
| Country | China |
| Company sponsor | Peking University |
| Other ID(s) | JWTCR001001 |
| Cohort 1 | |||||||||||
|
|||||||||||